MedTrace Logo

Evaluation of Crestor® (Rosuvastatin) in Daily Practice

NCT00837083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 602

Last updated 2009-02-06

No results posted yet for this study

Summary

This open label, non-interventional study is to show the efficacy of Crestor (rosuvastatin) in reduction of LDL-cholesterol and cardiovascular risk parameters in patients with hypercholesterolemia. Effectiveness is to be evaluated using the difference in LDL cholesterol level between the first and the second visit after 12 weeks.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Matija Cevc, MD · University Medical Centre Ljubljana

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2007-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00837083 on ClinicalTrials.gov